359 related articles for article (PubMed ID: 26267490)
1. Autofluorescence imaging in recurrent oral squamous cell carcinoma.
Scheer M; Fuss J; Derman MA; Kreppel M; Neugebauer J; Rothamel D; Drebber U; Zoeller JE
Oral Maxillofac Surg; 2016 Mar; 20(1):27-33. PubMed ID: 26267490
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the diagnostic efficacy and spectrum of autofluorescence of benign, dysplastic and malignant lesions of the oral cavity using VELscope.
Ganga RS; Gundre D; Bansal S; Shirsat PM; Prasad P; Desai RS
Oral Oncol; 2017 Dec; 75():67-74. PubMed ID: 29224826
[TBL] [Abstract][Full Text] [Related]
3. Patterns of differentially expressed genes in oral mucosal lesions visualised under autofluorescence (VELscope(™) ).
Kordbacheh F; Bhatia N; Farah CS
Oral Dis; 2016 May; 22(4):285-96. PubMed ID: 26749103
[TBL] [Abstract][Full Text] [Related]
4. Clinical evaluation of an autofluorescence diagnostic device for oral cancer detection: a prospective randomized diagnostic study.
Rana M; Zapf A; Kuehle M; Gellrich NC; Eckardt AM
Eur J Cancer Prev; 2012 Sep; 21(5):460-6. PubMed ID: 22217551
[TBL] [Abstract][Full Text] [Related]
5. Salvage treatment for recurrent squamous cell carcinoma of the oral cavity.
Schwartz GJ; Mehta RH; Wenig BL; Shaligram C; Portugal LG
Head Neck; 2000 Jan; 22(1):34-41. PubMed ID: 10585603
[TBL] [Abstract][Full Text] [Related]
6. Fluorescence based characterization of early oral squamous cell carcinoma using the Visually Enhanced Light Scope technique.
Burian E; Schulz C; Probst F; Palla B; Tröltzsch M; Maglitto F; Califano L; Ehrenfeld M; Otto S
J Craniomaxillofac Surg; 2017 Sep; 45(9):1526-1530. PubMed ID: 28688861
[TBL] [Abstract][Full Text] [Related]
7. Detection of recurrent oral squamous cell carcinoma by [18F]-2-fluorodeoxyglucose-positron emission tomography: implications for prognosis and patient management.
Kunkel M; Förster GJ; Reichert TE; Jeong JH; Benz P; Bartenstein P; Wagner W; Whiteside TL
Cancer; 2003 Nov; 98(10):2257-65. PubMed ID: 14601097
[TBL] [Abstract][Full Text] [Related]
8. Squamous cell carcinoma of the buccal mucosa: one institution's experience with 119 previously untreated patients.
Diaz EM; Holsinger FC; Zuniga ER; Roberts DB; Sorensen DM
Head Neck; 2003 Apr; 25(4):267-73. PubMed ID: 12658730
[TBL] [Abstract][Full Text] [Related]
9. Spectroscopic characterization of oral epithelial dysplasia and squamous cell carcinoma using multiphoton autofluorescence micro-spectroscopy.
Pal R; Edward K; Ma L; Qiu S; Vargas G
Lasers Surg Med; 2017 Nov; 49(9):866-873. PubMed ID: 28677822
[TBL] [Abstract][Full Text] [Related]
10. [Computed tomographic appearance of the recurrent patterns of oropharyngeal and oral cavity squamous cell carcinomas].
Sasaki F; Kido C
Rinsho Hoshasen; 1988 Oct; 33(10):1071-7. PubMed ID: 3210328
[No Abstract] [Full Text] [Related]
11. Impact of treatment sequence of multimodal therapy for advanced oral cavity cancer with mandible invasion.
Myers LL; Sumer BD; Truelson JM; Nedzi L; Perkins S; Hughes RS; Ahn C
Otolaryngol Head Neck Surg; 2011 Dec; 145(6):961-6. PubMed ID: 21810773
[TBL] [Abstract][Full Text] [Related]
12. Autofluorescence imaging of potentially malignant mucosa lesions.
Scheer M; Neugebauer J; Derman A; Fuss J; Drebber U; Zoeller JE
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 May; 111(5):568-77. PubMed ID: 21429774
[TBL] [Abstract][Full Text] [Related]
13. Does autofluorescence help detect recurrent squamous cell carcinoma? A prospective clinical study.
Schorn L; Rana M; Madry A; Ipaktchi R; Möllmann H; Gellrich NC; Rana M
Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Sep; 130(3):258-263. PubMed ID: 32593620
[TBL] [Abstract][Full Text] [Related]
14. Staging of the neck in patients with oral cavity squamous cell carcinomas: a prospective comparison of PET, ultrasound, CT and MRI.
Stuckensen T; Kovács AF; Adams S; Baum RP
J Craniomaxillofac Surg; 2000 Dec; 28(6):319-24. PubMed ID: 11465137
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of tissue autofluorescence imaging (VELScope) in the visualization of oral mucosal lesions.
Farah CS; McIntosh L; Georgiou A; McCullough MJ
Head Neck; 2012 Jun; 34(6):856-62. PubMed ID: 21818819
[TBL] [Abstract][Full Text] [Related]
16. Clinical values of (18) F-FDG PET/CT in oral cavity cancer with dental artifacts on CT or MRI.
Hong HR; Jin S; Koo HJ; Roh JL; Kim JS; Cho KJ; Choi SH; Nam SY; Kim SY
J Surg Oncol; 2014 Nov; 110(6):696-701. PubMed ID: 24995957
[TBL] [Abstract][Full Text] [Related]
17. Recurrent oral cavity cancer: Patterns of failure after salvage multimodality therapy.
Quinlan-Davidson SR; Morrison WH; Myers JN; Gunn GB; William WN; Beadle BM; Skinner HD; Gillenwater AM; Frank SJ; Phan J; Johnson FM; Fuller CD; Zafereo ME; Rosenthal DI; Garden AS
Head Neck; 2017 Apr; 39(4):633-638. PubMed ID: 28006086
[TBL] [Abstract][Full Text] [Related]
18. The advantages and drawbacks of routine magnetic resonance imaging for long-term post-treatment locoregional surveillance of oral cavity squamous cell carcinoma.
Al-Shwaiheen FA; Wang SJ; Uzelac A; Yom SS; Ryan WR
Am J Otolaryngol; 2015; 36(3):415-23. PubMed ID: 25697087
[TBL] [Abstract][Full Text] [Related]
19. Utility of FDG PET in patients with squamous cell carcinomas of the oral cavity.
Kim SY; Roh JL; Kim JS; Ryu CH; Lee JH; Cho KJ; Choi SH; Nam SY
Eur J Surg Oncol; 2008 Feb; 34(2):208-15. PubMed ID: 17482789
[TBL] [Abstract][Full Text] [Related]
20. The detection of oral pre- malignant lesions with an autofluorescence based imaging system (VELscope™) - a single blinded clinical evaluation.
Hanken H; Kraatz J; Smeets R; Heiland M; Assaf AT; Blessmann M; Eichhorn W; Clauditz TS; Gröbe A; Kolk A; Rana M
Head Face Med; 2013 Aug; 9():23. PubMed ID: 23967796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
